Medical Treatment of Benign Prostatic Hyperplasia

Reviews in Urology

Herbert Lepor¹ 

[1] New York University School of Medicine, New York, NY

关键词: Benign prostatic hyperplasia;    Lower urinary tract symptoms;    Monotherapy;    Combination therapy;   

DOI  :  

学科分类：基础医学

来源: MedReviews, LLC

【 摘 要 】

Medical therapy for the treatment of benign prostatic hyperplasia (BPH) became an accepted standard of care in the 1990s following the reports of randomized, double-blind, placebo-controlled studies showing that finasteride, a 5-α reductase inhibitor, and terazosin, an α-blocker, significantly improved lower urinary tract symptoms and increased peak urinary flow rates in men with BPH. This article reviews novel approaches to the pharmacological treatment of BPH.

【 授权许可】

Unknown